Markets
FRA-PARIS-SNACK SHOW
(Getty Images)

Beyond Meat tumbles as CEO blames American society for its business struggles after issuing weak sales outlook

The CEO equivalent of flipping over the table when board game night isn’t going well.

Beyond Meat is tanking on Wednesday after the plant-based meat company issued an underwhelming Q1 sales outlook. The firm expects net revenues for the current quarter to come in between $57 million and $59 million, while Wall Street was looking for $66.7 million.

CEO Ethan Brown offered a novel, all-encompassing excuse for its travails.

TL;DR: we’re not struggling because we’re a bad business. We’re struggling because American society is in a bad place.

Here’s Brown on the conference call:

If I thought that Beyond, in our original value proposition, were struggling during a period when the role of science and public discourse and social media, media and government, was pronounced and effective when pricing and economic stability and buying power were all favorable, and the American political landscape were characterized by a sense of common ground versus division, and Beyond were really suffering, I would be very concerned for our long-term prospects and for the plant-based meat category overall. But none of that is true, right?

This is a very difficult period for the world, and its a difficult period for our country. And I think one of the things that is most significant for our business in terms of whats impacting it is this kind of surround sound of pseudoscientific jargon and positioning and promotion that really overwhelms what is decades and decades and decades of science. And I think nothing in our lane is a more obvious representation of this troubling trend than the resurgence of red meat.

And Ive spent over 17 years now seeking and listening to the counsel of some of the very best cardiologists in the country at some of our most prestigious institutions. And I can only look at these current trends with a mixture of sadness for the folks that are going to be impacted by it and increased impatience for those that are seeking to profit from it...

The remarks are a not-so-thinly veiled jab at the MAHA (or “Make America Healthy Again”) movement popularized by Human and Health Services Secretary Robert F. Kennedy Jr., who has advocated in favor of eating more red meat. Beyond’s downward revenue trajectory, however, far predates President Donald Trump’s second term in office.

Investors have to take the world as it is and how they expect it to evolve when making decisions about where to put their capital, rather than idealized versions of what the world “should” be and how different businesses might perform in that utopian environment. And it’s the job of leaders to position their organizations to thrive in the world that is and will be.

“But the good news is that this is a pendulum,” Brown added. “Its going to swing, and its going to swing back, and Im very comfortable that Beyond will prosper when it does, but Im not going to wait around for that.”

Beyond Meat remains unable to file its annual report in a timely fashion after discovering more accounting irregularities while in the process of addressing previously detailed accounting issues.

More Markets

See all Markets
markets

Nike craters after issuing weak revenue guidance

Sportswear kingpin Nike is tumbling on Wednesday morning after saying it doesn’t expect to grow sales this year.

On its fiscal Q3 earnings call, management said that revenue is expected to drop 2% to 4% in the current quarter, and that overall they “expect revenues to be down low-single-digits versus the prior year, with gains in North America offset by declines in Greater China.” That’s a disappointment to analysts, who were anticipating 2% growth in Q4 and even more in the latter stages of the year, per Bloomberg.

Nike’s Q3 sales in China — where the company earns about 15% of its revenue — fell 7% to $1.62 billion. The company had issued weak guidance for this quarter considering continued softness in the region. That’s its seventh straight quarter of sales declines in the market. While this quarter’s was decline was less than feared, management warned that more pain is in the offing.

Nike’s turnaround effort “is complex work, and parts of it are taking longer than I’d like,” said CEO Elliott Hill.

Nike’s fiscal Q3 results (the three months ended February) were solid at the headline level:

  • Earnings of $0.35 per share, comfortably above the Wall Street consensus estimate of $0.29 per share compiled by FactSet.

  • $11.28 billion in total revenue, roughly in line with the $11.26 billion estimate.

But the gloomy sales outlook has Wall Street analysts souring on the stock:

  • JPMorgan downgraded the shares to “neutral” from “overweight” and cut its price target to $52 from $86.

  • Citi reduced its target price to $53 from $65,

  • Stifel lowered its price target to $56 from $65,

  • Truist reduced its price target to $57 from $69, and

  • Barclays cut its target price to $67 from $73.

Nike shares are trading near decade lows this month, as tariffs continue to weigh on profits and shipping costs rise amid the war with Iran. As of Tuesday’s close, the stock was down 17% year to date.

Oil-sensitive travel stocks pop following Iran state media reporting on potential war resolution

Travel stocks are surging on Tuesday as oil prices fall following reports from Iranian state media that President Masoud Pezeshkian said the country has the necessary will to end this war, but would only do so with guarantees that prevent the recurrence of aggression.

The war has sent oil prices and refining margins surging this month, causing airlines and cruise lines to cut profit forecasts despite reported high demand.

Following Tuesday’s update, shares of the big four US airlines (Delta Air Lines, United Airlines, American Airlines, and Southwest Airlines) all climbed, along with smaller rivals including JetBlue. US airlines have stopped fuel hedging in recent years, increasing their exposure to upward swings in oil prices.

Cruise stocks also rallied, with Carnival and Norwegian up more than 6% and Royal Caribbean up about 5%.

markets

The FDA is expected to lift restrictions on certain peptides, the NYT reports

The Food and Drug Administration is expected to lift restrictions on certain peptides, allowing the experimental, often injectable substances to be sold by compounding pharmacies, The New York Times reported Tuesday.

The potential move was previously reported by The Wall Street Journal, and teased by Health Secretary Robert F. Kennedy Jr. on the “Joe Rogan Experience” podcast in late February.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.